Search

Search Results
Results 4051 - 4060 of 5284 for Active site
  • Metalyse 25 mg
    Drug - 24 Jul 2025
    Consumer Medicine Information (CMI) about Metalyse 25 mg intended for persons living in Australia.
  • Zavedos
    Drug - 18 Jul 2025
    Consumer Medicine Information (CMI) about Zavedos intended for persons living in Australia.
  • DBL Pethidine Hydrochloride
    Drug - 17 Jul 2025
    Consumer Medicine Information (CMI) about DBL Pethidine Hydrochloride intended for persons living in Australia.
  • Prevenar 13
    Drug - 15 Jul 2025
    Consumer Medicine Information (CMI) about Prevenar 13 intended for persons living in Australia.
  • Risvan
    Drug - 10 Jul 2025
    Consumer Medicine Information (CMI) about Risvan intended for persons living in Australia.
  • Nexium Intravenous
    Drug - 25 Jun 2025
    Consumer Medicine Information (CMI) about Nexium Intravenous intended for persons living in Australia.
  • Quadracel
    Drug - 18 Jun 2025
    Consumer Medicine Information (CMI) about Quadracel intended for persons living in Australia.
  • Relenza
    Drug - 16 Jun 2025
    Consumer Medicine Information (CMI) about Relenza intended for persons living in Australia.
  • What drives insulin resistance? Proteomics reveals key pathways in human skeletal muscle
    News - 30 May 2025
    Identifying proteomic signatures of insulin resistance in fasting muscle offers insights for personalized type 2 diabetes therapies based on molecular profiles.
  • Call centers replaced many doctors’ receptionists. Now, AI is coming for call centers.
    News - 22 May 2025
    At one call center in the Philippines, workers help Americans with diabetes or neurological conditions troubleshoot devices that monitor their health.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback